Find a Doctor or Practice Location

Are you a referring physician?
I am searching for a
Reset Form
Daniel J. Landsburg, MD

Daniel J. Landsburg, MD Physician

Assistant Professor of Clinical Medicine

Dr. Landsburg is a Penn Medicine employed physician.

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Patient Comments

Clinical Specialties


  • Hematology
  • Medical Oncology

Programs & Centers:

Board Certification:

  • Hematology, 2014
  • Internal Medicine, 2011
  • Medical Oncology, 2014

Clinical Expertise:

  • Bone Marrow Transplant
  • Cutaneous T-Cell Lymphoma
  • Lymphoma
  • Stem Cell Transplant

Description of Clinical Expertise

Non-Hodgkin lymphoma
Hodgkin lymphoma
Autologous stem cell transplantation

Practice Locations and Appointments

  • Abramson Cancer Center

    Perelman Center for Advanced Medicine West Pavilion, 2nd Floor 3400 Civic Center Boulevard Philadelphia, PA 19104 800-789-7366 (PENN)

    A facility of the Hospital of the University of Pennsylvania

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: Temple University School of Medicine
Residency: Hospital of the University of Pennsylvania
Fellowship: Hospital of the University of Pennsylvania


American Society of Clinical Oncology, International American Society of Hematology, International

Hospital Affiliation

Dr. Landsburg is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.


Description of Research Expertise:

"Double-hit" B cell lymphoma
MYC-altered B cell lymphoma
Diffuse large B cell lymphoma

Selected Publications:

Landsburg Daniel J, Falkiewicz Marissa K, Petrich Adam M, Chu Benjamin A, Behdad Amir, Li Shaoying, Medeiros L Jeffrey, Cassaday Ryan D, Reddy Nishitha M, Bast Martin A, Vose Julie M, Kruczek Kimberly R, Smith Scott E, Patel Priyank, Hernandez-Ilizaliturri Francisco, Karmali Reem, Rajguru Saurabh, Yang David T, Maly Joseph J, Blum Kristie A, Zhao Weiqiang, Vanslambrouck Charles, Nabhan Chadi: Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable. British journal of haematology 175 (4): 631-640,2016.

Landsburg Daniel J: Management of Patients with MYC-Altered Lymphomas Current Hematologic Malignancy Reports 11 (3): 208-17,2016.

Landsburg Daniel J, Schuster Stephen J: Who Should Be Tested for Double-Hit Lymphoma? Journal of Oncology Practice/American Society of Clinical Oncology 12 (3): 243-4,2016.

Landsburg Daniel J, Petrich Adam M, Abramson Jeremy S, Sohani Aliyah R, Press Oliver, Cassaday Ryan, Chavez Julio C, Song Kevin, Zelenetz Andrew D, Gandhi Mitul, Shah Namrata, Fenske Timothy S, Jaso Jesse, Medeiros L Jeffrey, Yang David T, Nabhan Chadi: Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma. Cancer 122 (4): 559-64,2015.

Luskin Marlise R, Ganetsky Alex, Landsburg Daniel J, Loren Alison W, Porter David L, Nasta Sunita D, Svoboda Jakub, Luger Selina M, Frey Noelle V: Nelarabine, cyclosphosphamide and etoposide for adults with relapsed T-cell acute lymphoblastic leukaemia and lymphoma. British Journal of Haematology 174 (2): 332-334,2016.

Howlett Christina, Snedecor Sonya J, Landsburg Daniel J, Svoboda Jakub, Chong Elise A, Schuster Stephen J, Nasta Sunita Dwivedy, Feldman Tatyana, Rago Allison, Walsh Kristy M, Weber Scott, Goy Andre, Mato Anthony: Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis. British Journal of Haematology 170 (4): 504-14,2015.

Petrich Adam M, Gandhi Mitul, Jovanovic Borko, Castillo Jorge J, Rajguru Saurabh, Yang David T, Shah Khushboo A, Whyman Jeremy D, Lansigan Frederick, Hernandez-Ilizaliturri Francisco J, Lee Lisa X, Barta Stefan K, Melinamani Shruthi, Karmali Reem, Adeimy Camille, Smith Scott, Dalal Neil, Nabhan Chadi, Peace David, Vose Julie, Evens Andrew M, Shah Namrata, Fenske Timothy, Zelenetz Andrew D, Landsburg Daniel J, Howlett Christina, Mato Anthony, Jaglal Michael, Chavez Julio C, Tsai Judy P, Reddy Nishitha, Li Sh: Impact of induction regimen and stem cell transplantation on outcomes in patients with double hit lymphoma: a large multicenter retrospective analysis. Blood 124 (15): 2354-61,2014.

Frosch Zachary, Luskin Marlise R, Landsburg Daniel J, Schuster Stephen J, Svoboda Jakub, Loren Alison W, Porter David L, Stadtmauer Edward A, Nasta Sunita D: R-CHOP or R-HyperCVAD With or Without Autologous Stem Cell Transplantation for Older Patients With Mantle Cell Lymphoma. Clinical Lymphoma, Myeloma & Leukemia 15 (2): 92-7,2014.

Landsburg Daniel J, Stadtmauer Edward, Loren Alison, Goldstein Steven, Frey Noelle, Nasta Sunita D, Porter David L, Tsai Donald E, Perl Alexander E, Hexner Elizabeth O, Luger Selina: Receipt of maintenance therapy is most predictive of survival in older acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens. American Journal of Hematology 88 (8): 657-60,2013.

Landsburg Daniel J, Nasta Sunita D, Svoboda Jakub, Morrissette Jennifer J D, Schuster Stephen J: 'Double-Hit' cytogenetic status may not be predicted by baseline clinicopathological characteristics and is highly associated with overall survival in B cell lymphoma patients. British Journal of Haematology 166 (3): 369-74,2014.

Landsburg DJ, Schuster SJ, Svoboda J, Nasta SD: Could treatment with R-HCVAD/R-MA as compared to R-CHOP truly result in improved outcomes for patients with high-risk diffuse large B cell lymphoma? Br J Haematol. 165 (1): 145-6,2013.

Academic Contact Info

Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-161
3400 Civic Center Boulevard

Philadelphia, PA 19104
Phone: 215-615-7361
Fax: 215-615-5888
Patient appointments: 800-789-7366 (PENN)